Curative Biosciences, Inc. is engaged in the development and marketing of novel therapeutics. The company is headquartered in Miami, Florida. The company went IPO on 2004-08-26. The Company’s product segment is focused on manufacturing, marketing and selling plant-based CBD products to a range of market sectors. The firm through its consumer products business manufactures market and sells consumer products containing plant-based CBD under the brand Curative Biosciences.
Curative Biosciences Inc'in kazanç kalite puanı B/41.61179'dir. Puan, karlılık, büyüme, nakit üretimi ve sermaye tahsisi ile kaldıraç olmak üzere dört boyuta dayanır.
Curative Biosciences Inc kazançlarını ne zaman rapor eder?
Curative Biosciences Inc'in bir sonraki kazanç raporu 'te bekleniyor